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Introduction
Vitamin has vital functions in human physiology. Frank vitamin D deficiency is associated with rickets and osteomalacia [1] , but less marked deficiency can also result in ill health [2, 3] . Outcomes: Knee and hip pain Self-reported knee and hip pain for the last 30 days was assessed by questionnaire using the Western Ontario McMaster Osteoarthritis Index (WOMAC)[23] as previously described [24] , with only the pain scale reported here. Briefly, the WOMAC pain scale has five items, each rated on a 10-point numeric rating scale from 0 (no pain) to 9 (most severe pain) [23] . Each pain item was summed to create a total pain (0-45) score. Knee pain was assessed at Phase 1 and 3, and hip pain at Phases 2 and 3; therefore change in knee pain is over 5 years and change in hip pain over 2.4 years. Change in WOMAC score was calculated as (follow-up valuebaseline value) with difference 1 indicating worsening and ≤-1 improvement in knee pain.
Knee and hip radiographs
Participants had X-rays of hips (n=639) and knees (n=711) in the standing anterioposterior (AP) position at baseline only. Knee X-rays were taken of both knees with 15° of fixed knee flexion, and pelvic radiographs with both feet in 10° internal rotation. Films were scored individually for osteophytes and joint space narrowing 
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Deleted: Prevalent pain was defined as a total WOMAC score of ≥1, but the total score was also analysed as a continuous measure. Knee bone marrow lesions and cartilage defects Bone marrow lesions and cartilage defects of the knee were assessed on MR images of the right knee, acquired with a 1.5T whole-body magnetic resonance unit (Picker, Cleveland, OH, USA) using a commercial transmit-receive extremity coil at baseline. BMLs were assessed on T2-weighted fat saturation 2D fast spin echo MR images using Osiris software as previously described [27] , and were defined as areas of increased signal adjacent to the subcortical bone at the medial tibial, medial femoral, lateral tibial, and lateral femoral sites. BMLs were dichotomised as being present (BML area >0 mm) or absent (BML area = 0 mm). 
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Other factors
Leg strength was measured to the nearest kilogram in both legs simultaneously, using a dynamometer (TTM Muscular Meter, Tokyo, Japan) as previously described [29] . BMI was calculated [weight (in kilograms)/height (in meters) 2 ] using weight measured to the nearest 0.1 kg (with shoes, socks, bulky clothing and headwear removed) using a single pair of calibrated electronic scales (Seca Delta Model 707), and height measured to the nearest 0.1 cm (with shoes and socks removed) using a stadiometer. Alcohol intake was assessed by a validated dietary questionnaire (The Cancer Council Victoria, Victoria, Australia) [30] as previously described [31] , and measured in glasses per day.
Statistical methods
We used Stata 12.0 (StataCorp LP) for statistical analyses. Statistical significance was set as a p value ≤0.05 (two-tailed). Differences in sample characteristics between participants whose pain worsened by ≥1 unit and those in whom pain was unchanged or improved were assessed using students' t-tests or 2 tests. The association between 25-OHD and change in WOMAC pain scale was assessed using linear regression; first with 25-OHD as a continuous measure, then as a categorical measure. As a threshold effect was detected at 25 nmol/L (data not shown), data was dichotomised at this level. Models were adjusted first for age, sex, BMI and season (summer-autumn vs winter-spring) and then additionally adjusted for structural factors and factors associated with knee pain[27], or hip pain, as appropriate. Change scores were normally distributed, although leptokurtic due to a large number of participants without pain at both baseline and follow up.
Nevertheless, we reported results with robust standard errors to accommodate mild violations of homoskedasticity and normality of residuals.
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Results
Participants 764 participants had complete data for change in knee WOMAC score, and 765 for change in hip WOMAC score as well as baseline 25-OHD. Participants who did not complete Phase 3 were older, had higher BMI, lower serum 25-OHD levels and worse total knee WOMAC scores at baseline than those who remained in the study (Table 1) .
Descriptive data
The prevalence of knee pain (knee WOMAC score >0) was 53% (n=582) at Phase 1 and 45% (n=346) at Phase 3. Mean change in total WOMAC score over five years among participants who experienced incident or worsening knee pain was 4.6±4.7
(n=175, range 1-24). These participants had higher BMI, weaker leg strength, more cartilage defects, were more likely to have radiographic knee OA (including osteophytes), more likely to use pain medicines (all p≤0.05), and a trend to higher prevalence of knee BMLs (p=0.11) than participants whose pain remained static or improved ( Table 2) .
Prevalence of hip pain at Phase 2 was 35% (n=272) and 37% at Phase 3 (n=191), with mean change in total WOMAC score of 5.7±6.6 (n=187; range 1-40) amongst participants who experienced incident or worsening hip pain between Phases 2 and 3. These participants had higher BMI, weaker leg strength, were more likely to use pain medicines at Phase 1 (p≤0.05), and had a trend to older age than participants whose pain remained static or improved (p=0.08) ( Table 2) . (Table 3, Table 4 ). When data were dichotomised at 25 nmol/L, having 25-OHD <25 nmol/L predicted incident or worsening pain in total knee WOMAC score and two of the five subscales over 5 years. Effect sizes remained unchanged or strengthened after adjustment for baseline covariates.
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Deleted: , and a trend to worsening total hip WOMAC pain over 2.4 years Deleted: nalyses in Table 3 and Table  4 confirmed that a Similar patterns were present when change in hip pain was the outcome, over a shorter period of observation but coefficients were slightly smaller. Associations did not reach statistical significance in univariate or multivariate models (see Table 4 ).
Sensitivity analyses
Participants often had baseline and follow up interviews in different seasons, which could affect results. We therefore repeated analyses for the 18% (n=137) of participants who had their initial and follow-up interviews in the same season. Using multivariate model 1 ( This study is also the first to report on potential associations between 25-OHD and change in hip pain; effect sizes are of a similar magnitude and the same direction to those observed in the knee, though they did not reach statistical significance. While we cannot rule out that the lack of significance in associations between 25-OHD and hip pain indicates the lack of a true effect, the consistent pattern and direction of effect across pain subscales, and anatomical sites suggest that there may be an effect of moderate vitamin D deficiency on hip pain which we lacked the power to detect. Hip data was available over a shorter period of observation, compared to the knee, potentially resulting in smaller effect sizes, and larger standard errors. These contributed to our inability to detect an effect should it be present. Replicating this analysis in either a larger sample or with a longer period of follow-up is needed to clarify this. We used baseline 25-OHD from one occasion, but since 25-OHD levels track over time [34] [35] [36] , this is a reasonable measure of usual 25-OHD status.
As knee pain is episodic, measuring change in knee pain between two time points over five years may miss real change during this period, thereby misclassifying pain status and diluting effect sizes. However, obesity measures [37] , and inflammatory markers[24] predicted change in knee pain in this cohort, in addition to low 25-OHD, suggesting that this is acceptable method.
There is moderate evidence suggesting that low 25-OHD may be positively associated with progression of radiographic OA [38] , but the association between 25-OHD and pain in our cohort was largely independent of other factors[27] as adjustment for these did not reduce the size of the beta coefficients and even increased them. Therefore, in our cohort, structural factors did not confound associations between 25-OHD and pain.
Low 25-OHD is associated with muscle weakness [39] , and dose-response associations between serum 25-OHD and appendicular muscle mass have been reported in our sample [40] , but the association between low serum 25-OHD and joint pain in our sample persisted after adjusting for leg muscle strength. Numerous studies have investigated associations between pain and structural features of knee and hip OA. However, adjusting for structural features of OA (eg osteophytes, JSN, cartilage defects) in our study did not decrease the association between low 25-OHD and knee pain on most subscales. Overall, this suggests the mechanism of the Further adjusted for leg strength, radiographic hip OA (present / absent), use of pain medications at baseline, and baseline WOMAC score (same scale eg baseline total hip WOMAC score for change in total hip WOMAC score). Change in WOMAC score is from Phase 2 to Phase 3 (2.4 years). Table and figure legends   Table 1 : Characteristics of study cohort at baseline in participants who did and did not complete Phase 3 Table 2 : Characteristics of study cohort at baseline Table 3 : Association between serum 25-OHD and change in knee pain over 5 years, as assessed by the WOMAC questionnaire Table 4 : Association between serum 25-OHD and change in hip pain over 2.4 years, as assessed by the WOMAC questionnaire 
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